These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38761870)
1. Towards a greater understanding of the deep eutectic phenomenon through examination of the lidocaine-NSAID therapeutic deep eutectic systems. Li S; Abdelquader MM; Andrews GP; Jones DS Eur J Pharm Biopharm; 2024 Jul; 200():114329. PubMed ID: 38761870 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications. Abdelquader MM; Li S; Andrews GP; Jones DS Eur J Pharm Biopharm; 2023 May; 186():85-104. PubMed ID: 36907368 [TBL] [Abstract][Full Text] [Related]
3. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES). Kalantri S; Vora A Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708 [TBL] [Abstract][Full Text] [Related]
5. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies. Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620 [TBL] [Abstract][Full Text] [Related]
6. Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system. Li S; Culkin A; Jones DS; Andrews GP Int J Pharm; 2021 Jan; 593():120071. PubMed ID: 33246048 [TBL] [Abstract][Full Text] [Related]
7. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives. Li Z; Lee PI Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143 [TBL] [Abstract][Full Text] [Related]
8. Design of arginine-based therapeutic deep eutectic solvents as drug solubilization vehicles for active pharmaceutical ingredients. Gutiérrez A; Aparicio S; Atilhan M Phys Chem Chem Phys; 2019 May; 21(20):10621-10634. PubMed ID: 31080981 [TBL] [Abstract][Full Text] [Related]
9. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology. Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248 [TBL] [Abstract][Full Text] [Related]
10. Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery. Balenzano G; Racaniello GF; Spennacchio A; Lopalco A; Iacobazzi RM; Lopedota AA; Laquintana V; Denora N Int J Pharm; 2024 Jun; 659():124267. PubMed ID: 38797251 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery. Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051 [TBL] [Abstract][Full Text] [Related]
12. Revealing Intermolecular Hydrogen Bonding Structure and Dynamics in a Deep Eutectic Pharmaceutical by Magic-Angle Spinning NMR Spectroscopy. Mann SK; Pham TN; McQueen LL; Lewandowski JR; Brown SP Mol Pharm; 2020 Feb; 17(2):622-631. PubMed ID: 31887061 [TBL] [Abstract][Full Text] [Related]
13. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen. Silva E; Oliveira F; Silva JM; Matias A; Reis RL; Duarte ARC Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33233659 [TBL] [Abstract][Full Text] [Related]
14. Selective terpene based therapeutic deep eutectic systems against colorectal cancer. Pereira J; Miguel Castro M; Santos F; Rita Jesus A; Paiva A; Oliveira F; Duarte ARC Eur J Pharm Biopharm; 2022 Jun; 175():13-26. PubMed ID: 35483600 [TBL] [Abstract][Full Text] [Related]
15. Impact of the Dicarboxylic Acid Chain Length on Intermolecular Interactions with Lidocaine. Zotova J; Twamley B; Tajber L Mol Pharm; 2022 Aug; 19(8):2980-2991. PubMed ID: 35850530 [TBL] [Abstract][Full Text] [Related]
16. Ionic liquid formation with deep eutectic forces at an atypical ratio (2:1) of naproxen to lidocaine in the solid-state, thermal characterization and FTIR investigation. Fiandaca M; Dalwadi G; Wigent R; Gupta P Int J Pharm; 2020 Feb; 575():118946. PubMed ID: 31837407 [TBL] [Abstract][Full Text] [Related]
17. Characterization and comparison of lidocaine-tetracaine and lidocaine-camphor eutectic mixtures based on their crystallization and hydrogen-bonding abilities. Gala U; Chuong MC; Varanasi R; Chauhan H AAPS PharmSciTech; 2015 Jun; 16(3):528-36. PubMed ID: 25370024 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Role of Deep Eutectic Solvents Based on Menthol and Saturated Fatty Acids on Wound Healing. Silva JM; Pereira CV; Mano F; Silva E; Castro VIB; Sá-Nogueira I; Reis RL; Paiva A; Matias AA; Duarte ARC ACS Appl Bio Mater; 2019 Oct; 2(10):4346-4355. PubMed ID: 32030369 [TBL] [Abstract][Full Text] [Related]
19. The effect of electrostatic interactions on the formation of pharmaceutical eutectics. Wojnarowska Z; Smolka W; Zotova J; Knapik-Kowalczuk J; Sherif A; Tajber L; Paluch M Phys Chem Chem Phys; 2018 Nov; 20(43):27361-27367. PubMed ID: 30357184 [TBL] [Abstract][Full Text] [Related]
20. Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents. Pereira CV; Silva JM; Rodrigues L; Reis RL; Paiva A; Duarte ARC; Matias A Sci Rep; 2019 Oct; 9(1):14926. PubMed ID: 31624310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]